The responses to intranasal insulin therapy, and the cortical response to systemic hyperinsulinemia are weaker in obese humans, suggesting that obesity renders the brain less responsive to insulin69, 70. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.